Oladapo, Abiola O.
Ito, Diane
Hibbard, Christopher
Bean, Stephanie E.
Krupnick, Robert N.
Ewenstein, Bruce M.
Article History
First Online: 30 July 2019
Compliance with Ethical Standards
:
: This research was funded by Baxalta US Inc., a member of the Takeda group of companies, Lexington, MA, USA. Medical writing/editorial support for this manuscript was provided by Mark Bowes, PhD, Sharon Suntag, MS, CMPP, and Eric Weathers, BA of IQVIA, Parsippany, NJ, USA, and by Paul Lidbury, PhD, employee of Excel Medical Affairs (Southport, CT, USA) and was funded by Baxalta US Inc., a Takeda company, Lexington, MA, USA. Study management and data analysis assistance were provided by Gabrielle Wilner, MHA of IQVIA, New York, NY, USA.
: Abiola O. Oladapo and Christopher Hibbard are employees of Baxalta US Inc., a Takeda company and Takeda stock owners. Diane Ito was an employee of Baxalta US Inc., a Takeda company at the time this work was conducted and holds stock and stock options. She is now an employee of Stratevi, Boston, MA, USA. Stephanie E. Bean was an employee of IQVIA at the time this work was conducted. She is now an employee of ClearView Healthcare Partners, New York, NY, USA. Robert N. Krupnick is an employee of IQVIA. Bruce M. Ewenstein is an employee of Baxalta US Inc., a Takeda company and holds equity positions.
: The raw data (transcripts) of this study cannot be shared, to maintain participant privacy. Summary data are available from the corresponding author on reasonable request.